VirtualScopics is a leader in providing quantitative imaging solutions that accelerate drug and medical device development. The company has developed a robust software platform for analyzing and modeling both structural and functional medical images. In combination with VirtualScopics’ industry-leading expertise in advanced imaging biomarker measurement, this platform offers a clear window into the biological activity of drugs and devices in clinical trial patients – which allows sponsors to make better and faster decisions. For more information, visit the company’s Web site at www.virtualscopics.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: